Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New devices for chronic ventricular support.

K L Franco1

  • 1Division of Cardiothoracic Surgery, University of Nebraska College of Medicine, Nebraska Medical Center, Omaha 68198-2315, USA. jkjfranco@aol.com

Journal of Cardiac Surgery
|February 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The future of the surgical treatment of dilated cardiomyopathy.

Journal of cardiac surgery·2000
Same author

Pseudoabscess of the aortic root caused by ectopic seating of an aortic prosthesis.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·1998
Same author

Mitral, tricuspid, and aortic valve repair or reconstruction.

Current opinion in cardiology·1997
Same author

Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation.

Journal of the American College of Cardiology·1996
Same author

Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction.

Circulation·1995
Same author

Optimal timing and indications for cholecystectomy in cardiac transplant patients.

World journal of surgery·1995
Same journal

Erratum.

Journal of cardiac surgery·2023
Same journal

Validity of direct bilateral axillary arterial cannulation in emergency surgery for acute type A aortic dissection.

Journal of cardiac surgery·2023
Same journal

Evaluation of midterm outcomes after Shone's complex surgery: Analysis of reoperation and mortality risk factors.

Journal of cardiac surgery·2023
Same journal

Subannular procedures on papillary muscles for secondary mitral valve regurgitation repair.

Journal of cardiac surgery·2022
Same journal

Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery.

Journal of cardiac surgery·2022
Same journal

Impact of rapid rehabilitation surgery on perioperative nursing in patients undergoing cardiac surgery: A meta-analysis.

Journal of cardiac surgery·2022
See all related articles

New mechanical cardiac assist devices offer an alternative to heart transplantation for congestive heart failure patients. These devices aim to improve quality of life and reduce mortality for eligible patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Congestive heart failure (CHF) impacts millions, with limited treatment options when medical/surgical therapies fail.
  • Heart transplantation is a viable option but faces organ shortages and immunosuppression complications.
  • Mechanical cardiac assist devices are emerging as critical alternatives for CHF patients.

Purpose of the Study:

  • To review novel cardiac assist devices developed recently.
  • To assess their potential as alternatives or bridges to heart transplantation.
  • To highlight devices nearing human clinical trials in the U.S.

Main Methods:

  • Review of recently developed pulsatile and nonpulsatile cardiac assist devices.
  • Focus on devices designed for chronic support in heart failure patients.

Related Experiment Videos

  • Identification of devices entering U.S. human clinical trials.

    • Main Results:

    • Several new cardiac assist devices show promise for chronic heart failure support.
    • These devices aim to provide adequate cardiac output, minimize thromboemboli, and reduce infection risk.
    • Many devices are nearing U.S. clinical trials as bridge-to-transplant or destination therapy.

    Conclusions:

    • Mechanical cardiac assist devices represent a significant advancement in managing advanced heart failure.
    • These devices may alleviate the limitations of heart transplantation, including donor organ scarcity.
    • Future clinical trials will determine the efficacy and safety of these innovative technologies.